Leidos Holdings entered this quarter with a value profile and a flat three month share price, then surprised the market with a 10% jump to about US$130.60 once investors saw the numbers. The company delivered Basic EPS of US$2.81 on revenue of US$4.56b, alongside record operating cash flow, which gave investors in this defense and government technology contractor specific results to reprice. The stock now reflects a sudden reset of expectations that were not fully captured in the modest returns seen before this earnings release.

Is Leidos Holdings really trading at a discount that aligns with its P/E of 11.9x and the suggested 48.4% gap to fair value, or is the market pricing in more risk than it appears? See how this current jump in earnings and cash flow lines up against the stock's implied upside in our valuation analysis for Leidos Holdings

Q2 2026 Earnings Summary

• Revenue, Q2 2026 vs. Q2 2025: US$4.56b vs. US$4.25b (up about 7%)
• Net Income, Q2 2026 vs. Q2 2025: US$354m vs. US$391m (down about 9%)
• Basic EPS, Q2 2026 vs. Q2 2025: US$2.81 vs. US$3.03 (down about 7%)
• Adjusted EBITDA Margin, Q2 2026 vs. Q2 2025: 13.8%, with the prior-year margin not disclosed (record adjusted EBITDA of US$631m on Q2 2026 revenue)

Prefer clear charts instead of scrolling through pages of earnings tables and cash flow figures? See Leidos Holdings' full visual breakdown of valuation, including how the market is currently pricing the stock after this quarter, in the company report for Leidos Holdings.

Leidos Bull Case Hinges On Defense And Cash Milestones

Bulls argue Leidos is shifting from a lower growth contractor into a higher quality defense tech, cyber, and energy platform under NorthStar 2030. This quarter gives some concrete proof points. Defense is the clearest. Organic growth in the segment is about 6% with margin expansion and a 2.2x book to bill in the quarter and 1.9x over 12 months. That lines up with the claim that programs are moving from development into production, backed by awards tied to hypersonics, counter UAS, munitions and missile warning satellites.

The narrative also leans heavily on cash generation and contract depth. Record operating cash flow of US$793m and free cash flow of US$761m support the idea that newer awards and portfolio shifts are turning into cash, not just revenue. A 1.1x company wide book to bill and raised full year revenue and EPS guidance further support the view that Leidos’ pipeline is converting into funded work.

Compare whether this earnings momentum and cash story for Leidos Holdings lines up with institutional expectations by checking the consensus price target analysis for Leidos Holdings.

Leidos Bear Case: Margin Strain And Health Drag Persist

The bearish story around Leidos Holdings centers on the risk that complex fixed price defense work, delayed awards and a pressured Health segment cap earnings power even when headline revenue looks healthy. This quarter gives that view some support. Revenue grew, yet net income fell about 9% and basic EPS fell about 7%. That points to cost and mix pressure, not just growth investments, and EBITDA margin guidance staying in the mid 13% range suggests no clear margin breakout yet.

Health concerns also remain. Management flagged revenue contraction in Health tied to a fourth vendor on the VBA medical disability exams contract and a pause in incentive payments through 2026. That is exactly the kind of contract restructuring and competition the bears worry about. Strong cash generation and a 1.1x company book to bill help offset these issues, but the key bear milestones on margin expansion and Health stability are not yet clearly beaten.

After rising debt, pressured margins and contract resets, are these issues isolated or part of deeper balance sheet stress? Review the risk analysis for Leidos Holdings which shows 1 important warning sign.

Stay Ahead With Simply Wall St

If the recent earnings jump and valuation debate around Leidos Holdings has your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and wait for a setup that fits your plan. Once you own Leidos Holdings or any other stock, use the Portfolio Command Center to cut through noise and focus on the updates that matter for your holdings. For ongoing ideas and context, tap into the Community to see how other investors are thinking about opportunities and risks. This approach can help surface hidden catalysts and potential red flags earlier so you stay one step ahead of the market.

Seeking Alternatives Beyond Leidos Holdings?

Fresh ideas can move fast. Some stocks are building quiet momentum, others are dropping back to attractive levels. Check these screeners before the crowd and get in early.

• Spot companies quietly building breakout potential by scanning a curated roster of resilient businesses in the 84 resilient stocks with low risk scores.
• Chase strong cash generators by reviewing hand picked 68 profitable AI stocks that aren't just burning cash that show real revenue muscle instead of just hype.
• Target durable income streams by checking a filtered set of 7 dividend fortresses that aim to keep distributions flying while staying backed by solid fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.